Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person During infection, viruses can trigger the assembly of the NO...

Class:IdSummation:9712403
_displayNameDuring infection, viruses can trigger the assembly of the NO...
_timestamp2021-07-13 03:16:02
created[InstanceEdit:9712406] Shamovsky, Veronica, 2021-01-19
literatureReference[LiteratureReference:874043] The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta
[LiteratureReference:844443] The inflammasomes
[LiteratureReference:879193] A unified model for apical caspase activation
[LiteratureReference:9712397] Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity
[LiteratureReference:9710021] Structural Mechanism for GSDMD Targeting by Autoprocessed Caspases in Pyroptosis
[LiteratureReference:9712409] Crystal structure of procaspase-1 zymogen domain reveals insight into inflammatory caspase autoactivation
[LiteratureReference:9712411] Substrate and inhibitor-induced dimerization and cooperativity in caspase-1 but not caspase-3
[LiteratureReference:9708068] The NLRP3 inflammasome: molecular activation and regulation to therapeutics
[LiteratureReference:9708079] Mechanism and Regulation of NLRP3 Inflammasome Activation
[LiteratureReference:9708040] Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
[LiteratureReference:9708036] Inflammasome activation and regulation: toward a better understanding of complex mechanisms
[LiteratureReference:9708063] The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity
[LiteratureReference:9708085] The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation
[LiteratureReference:9685266] MAVS Promotes Inflammasome Activation by Targeting ASC for K63-Linked Ubiquitination via the E3 Ligase TRAF3
[LiteratureReference:9712423] Cutting Edge: Mitochondrial Assembly of the NLRP3 Inflammasome Complex Is Initiated at Priming
modified[InstanceEdit:9712426] Shamovsky, Veronica, 2021-01-19
[InstanceEdit:9712432] Shamovsky, Veronica, 2021-01-19
[InstanceEdit:9735691] Shamovsky, Veronica, 2021-06-29
[InstanceEdit:9736587] Shamovsky, Veronica, 2021-07-13
textDuring infection, viruses can trigger the assembly of the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome complex on the mitochondrial surface (Elliott EI et al. 2018; Park S et al. 2013). The mitochondrial antiviral protein (MAVS) was shown to bind NLRP3 promoting the NLRP3 inflammasome activation at mitochondria (Subramanian N et al. 2013; Park S et al. 2013; Guan K et al. 2015). Infection of human THP-1 cells with Sendai virus (SV) led to MAVS-mediated NLRP3-dependent activation of caspase-1 (CASP1) (Park S et al. 2013). CASP1 exists as an inactive zymogen (CASP1(1-404)), which is recruited to the inflammasome complex through the C-terminal caspase recruitment domain (CARD) of PYCARD (ASC) (reviewed in Martinon F et al. 2002; Schroder K & Tschopp J 2010). Dimerization of zymogens is considered to be essential for the activation of caspases (Boatright KM et al. 2003; Boucher D et al. 2018; Wang K et al. 2020). PYCARD oligomerization promotes clustering and proximity-mediated self-cleavage of CASP1(1-404). It is assumed that the enzymatically active CASP1 in mammalian cells is a heterotetramer, which is composed of two p20 (CASP1(120-297)) and two p10 (CASP1(317-404)) subunits (a homodimer of p20:p10 dimers) (Elliott JM et al. 2009; Datta D et al. 2013). Once activated, p20:p10 species of CASP1 are released from the inflammasome complex for subsequent substrate cleavage. However, CASP1 can undergo self-cleavage at multiple sites within the two linker domains to potentially generate diverse dimeric CASP1 species such as a transient proteolytically active p33:p10 (CASP1(1-297):CASP1(317-404)) (Boucher D et al. 2018). The complex of inflammasome with p33:p10 heterodimer of CASP1 is thought to function as a holoenzyme that directs the location of CASP1 protease activity, while generation and release of p20:p10 species leads to the inactivation of CASP1 (Boucher D et al. 2018). The exact mechanism of the CASP1 activation requires further clarification.

This Reactome event shows autoprocessing of the dimeric CASP1(1-404) zymogen within the NLRP3 inflammasome bound to the mitochondrial MAVS. The cleavage releases the catalytic domain, which is composed of two covalently linked subunits, CASP1(120-297) and CASP1(317-404). The active form of CASP1 is shown as a homodimer of two catalytic domains, 2x(CASP1(120-297):CASP1(317-404)). Once activated, CASP1 cleaves pro‐inflammatory cytokines pro-interleukin (IL)‐1β, pro-IL‐18, and the pyroptotic cell death effector gasdermin D (GSDMD) (reviewed in He Y et al. 2016; Yang Y et al. 2019; Zheng D et al. 2020; Swanson KV et al. 2019).

(summation)[BlackBoxEvent:9712407] CASP1 is activated by autoproteolysis [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by During infection, viruses can trigger the assembly of the NO... (9712403)